Naveenkrishna Tarur, Principal Consultant Life Sciences Domain Consulting Group, Infosys, elaborates on the need to establish a credible roadmap for serialisation programme by pharma companies ...

Although there is a growing global trend among major pharmaceutical companies to introduce serialisation production line equipment, I would estimate, based on Mettler Toledo?s experience, that less ...

Recent research shows that the pharmaceutical industry is intensifying efforts to combat counterfeit drugs, which account for up to 30% of medicines sold globally. In a major step toward securing ...

Product-level serialisation has historically been associated with compliance mandates within highly regulated industries such as pharmaceuticals, medical devices, and tobacco. Its central premise was ...

Beyond serialisation – the use of on-dose authentication to protect patients and brands from the rising threat of counterfeit drugs With the World Health Organisation reporting that over half of all ...

The complexity within pharmaceutical supply chains is exceptional, with ingredients and medicines often crossing the borders of multiple countries before reaching the end consumer. Driven by patient ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...